complement alternative pathway
Selected indexed studies
- Low-molecular weight inhibitors of the alternative complement pathway. (Immunol Rev, 2023) [PMID:36217774]
- Immunodeficiency: Complement disorders. (Allergy Asthma Proc, 2024) [PMID:39294906]
- Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies. (Sci Rep, 2025) [PMID:39753879]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Immunodeficiency: Complement disorders. (2024) pubmed
- Low-molecular weight inhibitors of the alternative complement pathway. (2023) pubmed
- Complement classical and alternative pathway activation contributes to diabetic kidney disease progression: a glomerular proteomics on kidney biopsies. (2025) pubmed
- The alternative pathway of complement: a pattern recognition system. (2007) pubmed
- Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality. (2021) pubmed
- The spectrum of complement alternative pathway-mediated diseases. (2008) pubmed
- Analysis of the Complement System in the Clinical Immunology Laboratory. (2019) pubmed
- Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases. (2018) pubmed
- Alternative pathway of complement activation has a beneficial role against Chandipura virus infection. (2020) pubmed
- Alternative Complement Pathway Inhibition Abrogates Pneumococcal Opsonophagocytosis in Vaccine-Naïve, but Not in Vaccinated Individuals. (2021) pubmed